Ebola

Furin – the answer to the crises?

With an estimated fatality rate of 52%, the need to discover a cure for Ebola has never been more urgent. New research published in Journal of Biomolecular Structure and Dynamics this month suggests that scientists currently investigating potential cures for the Ebola virus should focus more attention on the protein furin.

Furin is responsible for activating certain proteins and is involved in the processing and maturation of viral and bacterial preproteins. Indeed, the strength of Furin activity has already been recognised, and used previously by scientists to propose broad anti-viral, anti-bacterial, and anti-cancer treatments. This study used the binding site of human Furin in molecular dynamics (MD) simulation.

Author of the study, Omotuyi  Olaposi, a lecturer in Biochemistry at the Adekunle Ajasin University, Nigeria, explains that the experiment ‘may provide further insight to the design of novel drugs for Ebola virus disease treatment’.

The study can be read online.
 

Source: Press Release Taylor & Francis Journals

18.11.2014

Read all latest stories

Related articles

Photo

News • Pilot clinical trial

China to test targeted therapy for COVID-19

A University of British Columbia (UBC) researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe…

Photo

Article • Medication development

Support from the other end of the world

Partners who could hardly be further apart – yet have a lot in common – have united to fight resistant pathogens. The International Consortium for Anti-Infective Research (iCAIR) is based in…

Photo

News • Championship with side effects

Football Euro: Study shows impact on Covid-19 infections

The European Football Championship in 2021 had an impact on the participating countries' coronavirus infections, a new study shows. However, the extent depended greatly on the initial situation.

Related products

Siemens Healthineers – Fast Track Real-time PCR assays

Infectious Disease

Siemens Healthineers – Fast Track Real-time PCR assays

Siemens Healthcare GmbH
Sarstedt - COVID-19 virus diagnostics products

Saliva Collection

Sarstedt - COVID-19 virus diagnostics products

SARSTEDT AG & CO. KG
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Mass Spectrometry

Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Shimadzu Europa GmbH
Subscribe to Newsletter